Unravel RWD with advanced analytical frameworks to strategically prepare for Commercial Biosimilar launch

Janani Damodaran

Consultant

Daniel Britto

Associate Consultant

Event Date: Wednesday, January 13th, 2021

Time: 12:00 p.m. ET

In the epoch of thriving Biosimilars launch phase, ever wondered why they haven’t been as successful as their reference Biologic product?

The conventional brand launch strategies fail when it comes to Biosimilar launches. There is a huge gap in terms of awareness about Biosimilar products, Bioequivalence, targeting, and messaging.

In case you have missed the live webinar – Unravel RWD with advanced analytical frameworks to strategically prepare for the Commercial Biosimilar launch, then you can watch the recorded webcast and access the presentation material at your convenience here.

 You will learn how to:

  1. Leverage RWD to build a robust analytical framework (targeting the most influential stakeholders)
  2. Positioning the Biosimilar for a strategic commercial launch

Make use of this extensive experience to strategically prepare for a successful Commercial Biosimilar launch.

 

Speaker Bios:

Janani is a Consultant at D Cube Analytics, she comes with 6+ years of experience in supporting Market Planning and Brand teams with analytical solutions to make strategic data-driven decisions. She has extensively worked on Oncology, Neuro, and Immunology therapeutic areas covering a spectrum of business problems – Pre/Post Drug Launch Strategic Analysis, Patient Chart Audits, Physician-level data analytics, Sales Force Effectiveness, and Primary Market Research.

Daniel is an Associate Consultant at D Cube Analytics, who has around 5+ years of experience in supporting the analytical needs of the regional and global brand teams in their quest towards building-up next-gen strategies across launch and pre-launch space. He brings in expertise in the Inflammation therapeutic area and has solved business problems pertaining to sales and commercial analytics, Payer and Provider analytics, and also Patient treatment dynamics by leveraging syndicated data sources and extensive market research

ABOUT D CUBE

D Cube Analytics is an Integrated Data Sciences company focused on extracting transformational insights from syndicated, real world and digital data to increase revenue realization, avert revenue loss, enhance internal productivity and improve end user experience for global Pharmaceutical organizations.

D Cube is pioneering a Digital Transformation wave within BioPharma by leveraging new age tools and methodologies like Artificial Intelligence, Machine Learning and Robotic Process Automation to greatly improve the productivity of workforce and significantly enhancing speed to insight. Through this new age product-based approach to delivering analytics, we greatly reduce the cost and complexity of deployments and provide measurable value across multiple business functions.

Find out how D Cube can help you to elevate your market access intelligence and develop rigorous strategies that enable success in the market, throughout the product life cycle.

Request Demo for DDSTM

Reach out to us at info@dcubeanalytics.com for information and questions.

Related Case Studies

Visit Us

D Cube Analytics
IndiQube Alpha Building
# 19/4 & 27, Ground Floor,
B2 & B3 Wings, Outer Ring Rd, Kadubeesanahalli, Panathur, Bengaluru,
Karnataka 560103

Visit Us

D Cube Analytics Inc.
1320 Tower Road,
Schaumburg,
Illinois 60173, USA

All Rights Reserved D Cube Analytics 2021